A patient with advanced cutaneous squamous cell carcinoma achieved a near complete response from immunotherapy.
Case Studies: The Challenges of Nasal Reconstruction
Two cases — both tremendously different in their level of complexity — illustrate the core principles of nasal reconstruction.
Practice-Changing Discovery for Treating BRAFV600-Mutant Melanoma
Study examines appropriate therapy sequence for patients with BRAFV600-mutant melanoma
Questions Remain about When to Employ Immunotherapy for Resected High-Risk Melanoma
Cleveland Clinic researchers aim to assess the appropriate timing and role of immunotherapies for treating advanced melanoma
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic Starts Shared Medical Appointments for Early Stage Melanoma Patients
Cleveland Clinic began offering shared medical appointments for early stage post-extraction melanoma patients in August hoping to change self-care behaviors and prevent recurrence of the disease.
Identifying a Novel Signaling Pathway in Skin Cancer
A Cleveland Clinic-led trial uncovered a novel signaling pathway in skin cancer that might be an important therapeutic target for certain cancers.
Cleveland Clinic’s Melanoma Program Enters Promising Era
Marc Ernstoff, MD, the recently appointed director of Cleveland Clinic’s Melanoma Program, cites a strong research base and advanced approaches to diagnoses and therapy as the enterprise’s distinguishing characteristics.